Ivan S. Coulter
Corporate Officer/Principal at Irish Research Council
Ivan S. Coulter active positions
Companies | Position | Start | End |
---|---|---|---|
Irish Research Council | Corporate Officer/Principal | - | - |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Consultant / Advisor | 01/08/2022 | - |
Career history of Ivan S. Coulter
Former positions of Ivan S. Coulter
Companies | Position | Start | End |
---|---|---|---|
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Chief Investment Officer | 01/08/2018 | 02/12/2019 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 01/05/2018 | 02/09/2018 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Chief Executive Officer | 01/08/2003 | 02/05/2018 |
Chief Tech/Sci/R&D Officer | 01/08/2003 | 02/05/2018 | |
Bord Iascaigh Mhara | Director/Board Member | 01/07/2007 | 02/08/2011 |
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Director/Board Member | 01/01/2003 | - |
Chief Executive Officer | 01/01/2003 | 23/05/2018 | |
Founder | 01/01/2003 | - |
Training of Ivan S. Coulter
Cornell University | Masters Business Admin |
University College Dublin | Doctorate Degree |
Statistics
International
Ireland | 6 |
United States | 3 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Consumer Services | 3 |
Health Technology | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Sublimity Therapeutics Ltd.
Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Irish Research Council | |
IIF Management Co. LLC
IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California. | Finance |
Atxa Therapeutics Ltd.
Atxa Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Atxa Therapeutics Ltd. is an Irish private company located in Belfield that operates as a pharmaceutical company that engages in research and development of committed to advancement of life-changing treatments for cardiopulmonary diseases. | Commercial Services |
Bord Iascaigh Mhara |
- Stock Market
- Insiders
- Ivan S. Coulter
- Experience